mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.1 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.1 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.1 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |